39.31
+0.15(+0.38%)
Currency In USD
| Previous Close | 39.16 |
| Open | 39.07 |
| Day High | 39.58 |
| Day Low | 37.94 |
| 52-Week High | 41.27 |
| 52-Week Low | 3.72 |
| Volume | 2.45M |
| Average Volume | 3.07M |
| Market Cap | 5.6B |
| PE | -19.18 |
| EPS | -2.05 |
| Moving Average 50 Days | 22.49 |
| Moving Average 200 Days | 11.83 |
| Change | 0.15 |
If you invested $1000 in Cogent Biosciences, Inc. (COGT) since IPO date, it would be worth $884.56 as of December 05, 2025 at a share price of $39.31. Whereas If you bought $1000 worth of Cogent Biosciences, Inc. (COGT) shares 5 years ago, it would be worth $3,080.72 as of December 05, 2025 at a share price of $39.31.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cogent Biosciences Announces Pricing of Concurrent Public Offerings of Common Stock and 1.625% Convertible Senior Notes Due 2031
GlobeNewswire Inc.
Nov 12, 2025 4:16 AM GMT
WALTHAM, Mass. and BOULDER, Colo., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (“Cogent”) (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the pricing
Cogent Biosciences Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2031 and Common Stock
GlobeNewswire Inc.
Nov 10, 2025 9:01 PM GMT
WALTHAM, Mass. and BOULDER, Colo., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (“Cogent”) (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that it has
Cogent Biosciences Reports Positive Results from Bezuclastinib PEAK Phase 3 Trial in Gastrointestinal Stromal Tumors (GIST)
GlobeNewswire Inc.
Nov 10, 2025 12:00 PM GMT
16.5 months median progression free survival (mPFS) for bezuclastinib plus sunitinib compared to 9.2 months mPFS for sunitinib monotherapy (HR=0.50, CI: 0.39-0.65; p<0.0001) 46% Objective Response Rate (ORR) reported for bezuclastinib combination com